Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Acute myeloid leukemia (AML)].

T Büchner1

  • 1Medizinische Universitätsklinik, Innere Medizin A, Westfälischen Wilhelms Universität Münster.

Praxis
|April 13, 1999
PubMed
Summary
This summary is machine-generated.

Environmental factors and age influence acute myeloid leukemia (AML). Treatment advances like chemotherapy and stem cell transplants improve survival rates for AML patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A consensus statement on how to conduct inclusive health research.

Journal of intellectual disability research : JIDR·2018
Same author

Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine.

Mycoses·2017
Same author

Properties of in situ generated gold nanoparticles in the cellular context.

Nanoscale·2017
Same author

A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients.

Leukemia·2017
Same author

Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (⩾60 years).

Bone marrow transplantation·2016
Same author

Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia.

Leukemia·2016
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Context:

  • Acute myeloid leukemia (AML) is influenced by environmental factors and age.
  • Morphological subtypes correlate with specific genotypes, including chromosome translocations and fusion genes.
  • Genotype significantly impacts AML biology and patient prognosis.

Purpose:

  • To review the current understanding of acute myeloid leukemia (AML) etiology, classification, and treatment strategies.
  • To highlight advancements in chemotherapy and stem cell transplantation for AML.
  • To discuss factors contributing to improved long-term survival in AML.

Summary:

  • Chemotherapy is the primary treatment for AML, achieving 30-40% long-term disease-free survival.
  • Improved outcomes are attributed to prolonged maintenance therapy, double induction strategies, and high-dose cytarabine (AraC).

Related Experiment Videos

  • Allogeneic bone marrow transplantation leverages the graft-versus-leukemia effect, while autologous stem cell transplantation may enable intensified chemotherapy.

    • Impact:

    • Current treatment strategies have significantly improved long-term survival rates in AML.
    • Further advancements in postremission chemotherapy and stem cell transplantation hold promise for enhancing cure rates.
    • Understanding genotype-specific disease biology is crucial for personalized AML treatment approaches.